Turkiye Cumhuriyeti Saglik Bakanligi

Their core work

Turkey's Ministry of Health (MOH) is the central government authority responsible for public health policy, disease surveillance, and healthcare service delivery across the country. Within H2020, MOH has acted as a demanding buyer of innovative health ICT solutions through Pre-Commercial Procurement (PCP), driving development of digital tools for chronic disease monitoring, patient empowerment, and occupational health. They bring large-scale healthcare system needs and real-world deployment environments that technology providers cannot easily access elsewhere.

What they specialise in

How they've shifted over time

MOH's early H2020 work (2016-2018) focused on foundational public health capacity — occupational health systems, disease registration, and data collection harmonisation (ESPrIT). From 2019 onward, their focus shifted decisively toward digital health innovation: ICT-based chronic disease monitoring (HSMonitor), AI-driven pandemic response (STAMINA), and integrated care models (INCAREHEART). The trajectory shows a ministry moving from traditional health data infrastructure toward intelligent, patient-facing digital health systems.

MOH is increasingly investing in AI and ICT for chronic disease management and crisis response, making them a strong demand-side partner for health tech innovators targeting large national healthcare systems.

How they like to work

MOH primarily leads projects — coordinating 3 out of 5, all through Pre-Commercial Procurement, where they act as the procuring authority defining healthcare needs that technology providers must solve. As a participant, they join larger consortia (STAMINA, INCAREHEART) to contribute real-world health system requirements and deployment environments. With 63 unique partners across 21 countries, they are a well-connected hub rather than a repeat-partner organization.

MOH has collaborated with 63 distinct partners across 21 countries, reflecting a broad European network unusual for a national ministry. Their PCP coordinator role means they attract diverse technology suppliers and healthcare organizations across the continent.

What sets them apart

MOH stands out as one of the few national health ministries that actively coordinates EU Pre-Commercial Procurement projects, making them a rare demand-side innovation driver rather than a passive policy body. For technology companies, partnering with MOH offers direct access to Turkey's 85-million-person healthcare system as a real-world testing and deployment environment. Their combination of procurement authority, regulatory influence, and clinical infrastructure is difficult to replicate through university or research institute partnerships.

Highlights from their portfolio

• HSMonitor
  Largest single project at EUR 4.5M — a PCP for innovative hypertension monitoring ICT, showing MOH's capacity to lead major procurement-driven innovation.
• STAMINA
  Marks MOH's entry into AI/ML for pandemic crisis management, directly relevant to post-COVID preparedness infrastructure.
• ProEmpower
  EUR 2.9M PCP for type 2 diabetes patient empowerment — demonstrates MOH's ability to define and procure patient-centered digital health solutions.